| Video
Healthcare providers often encounter aberrant behaviors from patients who are prescribed controlled substances. Pain practitioner Jeremy Adler outlines how forming a differential diagnosis of these, drawing on a consistent plan of action, and communicating with patients can contribute to more...
| Article
An editorial appearing earlier this week in the Journal of Pain Research and coauthored by senior PAINWeek faculty member Michael Schatman, PhD, CPE, DASPE, advocates for a fresh approach to threading the needle between efforts to address the crisis of opioid abuse and the legitimate needs of...
| Article
Although medication assisted treatment offers great promise for survivors of opioid overdose, a new study led by researchers from Johns Hopkins Bloomberg School of Public Health reports that it is being substantially underapplied at the epicenter of the opioid crisis. The study of nonfatal opioid...
| Article
Looking at medication options for substance use disorder, there is buprenorphine which is a full mu opioid agonist and also has an affinity to the kappa receptor which is what makes it lower liability in terms of abuse. Buprenorphine has been around for a long time. In the 1980s it was an injectable...
| Article
Researchers at University of California San Francisco have released a chilling analysis of the spread of illicitly produced fentanyl into the worldwide drug abuse marketplace. The study was undertaken in an effort to determine whether the increase in fentanyl-containing substances was more demand...
| Article
A study of almost 23,000 patients in North Carolina who were hospitalized for infective endocarditis found that 11% could be linked to the patient’s history of drug abuse, and that the incidence of IE admissions has escalated in step with the state’s crisis of opioid abuse. According to the authors...
| Article
An analysis conducted by researchers at University of Pittsburgh Graduate School of Public Health concludes that rising death rates from drug overdoses in the US long precede the now notorious “opioid crisis,” and that a near perfect exponential growth curve in these rates can be tracked back to the...
| Article
A small study conducted by researchers from the Center for Drug Use and HIV/HCV (CDUHR) at New York University concludes that managers and staff of publicly patronized business establishments can be effective first responders to incidents of opioid overdose, if they are properly trained. A prior...
| Article
The search for a new molecule in the face of the opioid crisis may have taken a major step forward with the recent discovery of a chemical compound, AT-121, that provides analgesia without addictive potential. Mei-Chuan Ko, PhD, professor of physiology and pharmacology at the School of Medicine...
| Article
New research led by a team from Binghamton University, State University at New York, concludes that single-step nasal spray delivery of naloxone is the easiest and most successful route of administration for members of the general community. Naloxone, also known by the brand name Narcan®, can be...